Competition & Markets Authority
CMA final decision on air traffic control charges
The CMA has sent the CAA its final price control determination on a dispute between the aviation regulator and NERL regarding air traffic control charges.
The Competition and Markets Authority (CMA) has acted as the independent body charged with looking into a price control dispute between the Civil Aviation (CAA) and NATS (En Route) Plc (NERL).
NERL is the subsidiary of NATS which holds a licence to provide en-route air traffic control services above the UK and the North Atlantic. NERL is regulated by the CAA.
NERL rejected the CAA’s price control decision for the 5 year period 2020-2024 and so the CAA referred the matter to the CMA for investigation.
The CMA’s investigation was underway before the coronavirus (COVID-19) pandemic. The pandemic has had a significant impact on air traffic and NERL’s operations, with the longer term effects remaining unknown. The CMA therefore had to consider how it should take account of the impact of the coronavirus in the final determination, and invited representations on this.
In light of the evidence received, the CMA has concluded that it is not yet possible to assess the full impact of the pandemic on the aviation industry and NERL’s business. The CMA has recognised that it is important for the industry and for NERL to have a clear framework within which to operate and has therefore based its final determination on the provisional findings, without making specific adjustments at this stage to take account of the impact of the coronavirus.
The practical effect of this approach is that for an interim period from 1 January 2020 to 31 December 2022, maximum charges for air traffic control services to airlines will in effect be set as if COVID-19 had not occurred. This will provide important certainty to both NATS and its customers until such time as the impact on the industry can be better understood and a more comprehensive reworking of the regulatory settlement to adjust for what actually happened during this period can be undertaken.
The CMA has decided on price control mechanisms that are largely in line with those proposed by the CAA with some adjustments in line with NERL’s submissions, and this will form the basis of the price control for an interim period from 1 January 2020 until 31 December 2022. The CAA will carry out a review of the price control within that time, which will include a reconciliation with actual data from the period affected by the coronavirus. The CMA final determination also requires improvements to capital expenditure governance and incentives which will apply beyond the 2020-2022 price control period.
Further information including a summary with details of the CMA’s findings can be found on the case page.
Latest News from
Competition & Markets Authority
CMA lifts the lid on impact of algorithms20/01/2021 12:20:00
The CMA has published new research on algorithms, showing how they can reduce competition in digital markets and harm consumers if they are misused.
Metallurgy firms abandon merger during CMA investigation19/01/2021 12:20:00
The CMA no longer intends to refer the merger of TTI and Tronox to an in-depth investigation, after Tronox’s announcement to abandon the deal.
CMA breaks up motor parts merger13/01/2021 12:20:00
The CMA will require TVS Europe Distribution to sell 3G in order to protect competition in the commercial vehicle and trailer parts sector.
CMA to investigate Google’s ‘Privacy Sandbox’ browser changes08/01/2021 14:25:00
The CMA has opened an investigation into Google’s proposals to remove third party cookies and other functionalities from its Chrome browser.
CMA to investigate NVIDIA’s takeover of Arm07/01/2021 12:20:00
The CMA is inviting interested third parties to provide initial views on the anticipated acquisition of Arm by NVIDIA.
Metallurgy buyout raises competition concerns05/01/2021 09:10:00
The CMA has found that Tronox’s anticipated purchase of TTI raises competition concerns in the supply of chloride slag and titanium dioxide pigment.
CMA secures affordable supply of key bipolar drug21/12/2020 10:20:00
The CMA has accepted legally binding commitments from Essential Pharma to continue supplying a key bipolar drug at an affordable price for at least 5 years.
CMA publishes final report in funerals market investigation21/12/2020 09:20:00
The CMA has published the final report on its in-depth market investigation into funeral services, confirming its remedies for the sector.